Researcher
INSERM U1176, Université Paris Saclay, Le Kremlin-Bicêtre, France
Le Kremlin-Bicêtre, Ile-de-France, France
Dr. Peter J. LENTING
Dr. Lenting obtained his PhD cum laude at the University of Amsterdam in 1996, while working at Sanquin Research. After holding positions as associate-professor of Hematology at the University Medical Center in Utrecht (2000-2007) and Director Protein/Antibody Discovery at Crucell Holland (2007-2009), Dr. Lenting works since 2009 as Director of Research at Inserm. His research focuses on fundamental and translational aspects of Hemophilia and von Willebrand disease. He has published >190 articles and is inventor on 14 patent applications. He has been elected as member of the council of the International Society of Thrombosis & Hemostasis (2012-2018) and the French Society of T & H (2017-2023), was chairman of the ISTH-WHO Standard Liaison group (2012-2018) and frequently participates in scientific advisory board meetings of pharmaceutical organizations. Dr. Lenting received the Prix Danièle Hermann (Institut de France) in 2009, the Arosenius Award (World Federation of Hemophilia) in 2022 and the van Creveld Medal (Dutch Society of T & H) in 2022 for his research activities.
EC 01.7 - The ISTH platforms for collaboration
Saturday, June 22, 2024
09:20 – 10:20 ICT
Sunday, June 23, 2024
13:45 – 14:45 ICT
Monday, June 24, 2024
14:45 – 16:00 ICT
Wednesday, June 26, 2024
10:30 – 10:45 ICT